EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HPV vaccination of immunocompromised hosts

S M Garland, J M L Brotherton, A B Moscicki, A M Kaufmann, M Stanley, N Bhatla, R Sankaranarayanan, S de Sanjosé, J M Palefsky, IPVS

Papillomavirus Research · 2017-12 · 4 · 35-38

DOI: 10.1016/j.pvr.2017.06.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Papillomavirus Research, 2017-12. Verfasst von S M Garland und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Infectious Diseases, Royal Women's Hospital, 30 Flemington Road, Parkville 3052, Australia; Murdoch Childrens Research…. Hauptthemen laut MEDLINE: Immunocompromised Host. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunocompromised HostAdolescentChildFemaleGuidelines as TopicHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18HumansImmunogenicity, VaccinePapillomavirus InfectionsPapillomavirus VaccinesVaccination

Stichwörter der Autor:innen

HPV GuidelinesHPV related cancersHuman papillomavirus (HPV)Immunocompromised hostsVaccination

Substanzen

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Microbiology and Infectious Diseases, Royal Women's Hospital, 30 Flemington Road, Parkville 3052, Australia; Murdoch Childrens Research Institute, 50 Flemington Road, Parkville 3052, Australia; Department…
  • VCS Registries, Victorian Cytology Service, Level 6, 176 Wellington Parade, East Melbourne 3002, Australia; School of Population and Global Health, University of Melbourne, Parkville 3052, Australia. Electronic address:…
  • Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Ave. MDCC 22-432, MC:175217, Los Angeles, CA 90095, United States. Electronic address: AMoscicki@mednet.uc…
  • Gynäkologische Tumorimmunologie, R. 4503 Gynäkologie, Charite-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany. Electronic address: Andreas.Kaufmann@charite.de.
  • Department of Pathology, Tennis Court Road, Cambridge CB2 1QP, United Kingdom. Electronic address: mas1001@cam.ac.uk.
  • Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi 110029, India. Electronic address: neerja.bhatla07@gmail.com.

Förderung

  • World Health Organization

Zitieren

APA

Garland, S. M., Brotherton, J. M. L., Moscicki, A. B., Kaufmann, A. M., Stanley, M., Bhatla, N., Sankaranarayanan, R., de Sanjosé, S., Palefsky, J. M., & IPVS (2017). HPV vaccination of immunocompromised hosts. Papillomavirus Research, 4, 35-38. https://doi.org/10.1016/j.pvr.2017.06.002

Vancouver

Garland SM, Brotherton JML, Moscicki AB, Kaufmann AM, Stanley M, Bhatla N, et al. HPV vaccination of immunocompromised hosts. Papillomavirus Research. 2017;4:35-38. doi:10.1016/j.pvr.2017.06.002

BibTeX
@article{Garland2017,
  author = {Garland, S M and Brotherton, J M L and Moscicki, A B and Kaufmann, A M and Stanley, M and Bhatla, N and Sankaranarayanan, R and de Sanjosé, S and Palefsky, J M and IPVS, IPVS},
  title = {HPV vaccination of immunocompromised hosts},
  journal = {Papillomavirus Research},
  year = {2017},
  volume = {4},
  pages = {35--38},
  doi = {10.1016/j.pvr.2017.06.002}
}
Kostenlos starten →